Search Medical Condition
Please enter condition
Please choose location

Lung Injury Clinical Trials

A listing of Lung Injury medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (19) clinical trials

The primary purpose of this study is to demonstrate improvements in lung function for subjects treated with UMEC/VI compared with UMEC for 24 weeks. The effect of UMC/VI, UMEC, and salmeterol with respect to patient HRQoL measured through patient reported outcomes (PROs) Questionnaires, symptoms and lung function will also be ...

Phase

This study is being done to learn more about the study drug, Nintedanib, and to learn if there are blood tests that can help see how the study drug affects IPF.

Phase

This is a research study for chronic pulmonary disease (COPD). Subjects who meet the criteria at Screening and meet the randomization criteria at the end of a Run In period will then enter the treatment phase of the study. Participation could last from 7 to 15 weeks. The study will ...

Phase N/A

This is a research study for chronic obstructive pulmonary disease (COPD). Subjects who meet inclusion criteria will be assigned to one of three doses of tiotropium. Two of these doses will be delivered via a novel inhalation device. The third dose will be delivered by the HandiHaler. This study is ...

Phase N/A

We are currently looking for study participants who have been diagnosed with COPD, Chronic Bronchitis or Emphysema. We currently have 3 different COPD studies that are being conducted at Clinsite. Please call or e-mail us for more information and to see if you qualify for one of our studies. Call ...

Phase N/A

This is a randomized, double-blind, multi-center, parallel group study to assess the efficacy and safety of BGF MDI 320/14.4/9.6 μg and BGF MDI 160/14.4/9.6 μg relative to GFF MDI 14.4/9.6 μg and BFF MDI 320/9.6 μg over a 52-week treatment period in 8,000 subjects with moderate to very severe COPD ...

Phase

A research study for former smokers both healthy and with COPD

Phase N/A

The primary purpose of this study is to demonstrate improvements in lung function for subjects treated with UMEC/VI compared with UMEC for 24 weeks. The effect of UMC/VI, UMEC, and salmeterol with respect to patient HRQoL measured through patient reported outcomes (PROs) Questionnaires, symptoms and lung function will also be ...

Phase